Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04522206 · ClinicalTrials.gov registry record · Phase 4
An Analysis of the Efficacy of a Pre-Emptive Multimodal Pain Regimen in Reducing Acute Post-Operative Pain and Narcotic Pain Medication Requirements in Spine Surgery
A Phase 4 study, sponsored by NYU Langone Health.
- Completed
- Registry status
- Phase 4
- Development phase
- 44
- Enrollment target
NCT04522206 is a Phase 4 study that has completed, run by NYU Langone Health. The registered enrollment target is 44 participants.
The verdict
NCT04522206, a Phase 4 study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 44 participants
- Enrollment target
Study Summary
The aim of this study is to investigate the hypothesis that multimodal pain regimen (consisting of acetaminophen, celecoxib, gabapentin, and oxycodone) administered pre-operatively before elective spine surgery significantly decreases acute pain post-operatively as well as decreasing requirements of post-op opioids for pain control in PACU as compared to patients undergoing elective spine surgery without a pre-operative pain regimen.
Interventions
- DRUG Pre-op Multimodal analgesia (MMA) regimen + standard post-op oxycodone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2020-08-20 |
| Est. Completion | 2021-06-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04522206
The ClinicalTrials.gov registry entry for NCT04522206 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pre-op Multimodal analgesia (MMA) regimen + standard post-op oxycodone is the first listed.
NCT04522206 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04522206 about?
NCT04522206 is a clinical study titled "An Analysis of the Efficacy of a Pre-Emptive Multimodal Pain Regimen in Reducing Acute Post-Operative Pain and Narcotic Pain Medication Requirements in Spine Surgery". The aim of this study is to investigate the hypothesis that multimodal pain regimen (consisting of acetaminophen, celecoxib, gabapentin, and oxycodone) administered pre-operatively before elective spine surgery significantly decreases acute pain post-operatively as well as decreasing requirements of...
What is the current status of trial NCT04522206?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 44 participants. The study started on 2020-08-20. Estimated completion is 2021-06-10.
What interventions are being tested in trial NCT04522206?
The interventions under investigation include: Pre-op Multimodal analgesia (MMA) regimen + standard post-op oxycodone (DRUG).
Who is sponsoring clinical trial NCT04522206?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.